CYAND - CYANOTECH CORP
0.29
0 0%
Share volume: 1,999
Last Updated: 03-26-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$0.29
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 12-31-2024 | 06-30-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q3 2024 | Q1 2025 | Q1 2026 | Q2 2025 | |
| Report Date | 06-20-2025 | 02-11-2025 | 08-06-2025 | 08-06-2025 | 11-10-2025 | |
| Assets | ||||||
| Total Assets | 25.112 M | 23.956 M | 22.995 M | 22.995 M | 24.027 M | |
| Current Assets | 10.591 M | 10.551 M | 10.523 M | 10.523 M | 11.931 M | |
| Inventories | 7.313 M | 7.751 M | 8.110 M | 8.110 M | 8.378 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 707.000 K | 359.000 K | 383.000 K | 383.000 K | 649.000 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 10.109 M | 9.256 M | 8.590 M | 8.590 M | 8.353 M | |
| Other Assets | 4.412 M | 4.149 M | 3.882 M | 3.882 M | 3.743 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 25.112 M | 23.956 M | 22.995 M | 22.995 M | 24.027 M | |
| Total liabilities | 13.298 M | 14.456 M | 14.995 M | 14.995 M | 15.962 M | |
| Total current liabilities | 8.554 M | 9.949 M | 10.778 M | 10.778 M | 11.892 M | |
| Accounts Payable | 1.439 M | 2.151 M | 2.234 M | 2.234 M | 2.971 M | |
| Other liabilities | 3.744 M | 3.507 M | 3.217 M | 3.217 M | 3.070 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 1.000 M | 1.000 M | 1.000 M | 1.000 M | 1.000 M | |
| Other liabilities | 3.744 M | 3.507 M | 3.217 M | 3.217 M | 3.070 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 11.814 M | 9.500 M | 8.000 M | 8.000 M | 8.065 M | |
| Common stock | 34.715 M | 34.977 M | 35.030 M | 35.030 M | 35.094 M | |
| Retained earnings | -22.901 M | -25.477 M | -27.030 M | -27.030 M | -27.029 M |